Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study
- PMID: 38459154
- DOI: 10.1007/s00277-024-05688-x
Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study
Abstract
Histological transformation into an aggressive B-cell lymphoma indicates a poor survival outcome for patients with indolent marginal zone lymphoma (MZL), which has been less studied. Large-scale data with long-term follow-up to investigate MZL transformation is limited. Here, by reporting a US-Nationwide cohort of 30,619 MZL patients diagnosed between 2000 and 2019, we found that transformation occurred in 2.08% (N = 624) of MZL cases, with the transformation incidence of 3.1 per 1,000 person-years. Advanced Ann Arbor stage, nodal MZL (NMZL) and splenic MZL (SMZL) were associated with an elevated risk of transformation. Certain subtype-specific characteristics, such as non-gastric extra-nodal MZL (vs. gastric, HR, 1.51, 95%CI 1.13-2.04; p = 0.006), and receiving splenectomy for SMZL (HR, 2.04, 95%CI 1.28-3.26; p = 0.003), also indicated a higher risk of transformation. Besides, transformation independently increased the overall mortality risk (HR, 1.38, 95%CI 1.24-1.53, p < 0.001), especially the higher lymphoma-caused mortality risk (HR, 3.21, 95%CI 2.81-3.67, p < 0.001). Transformation was also associated with a higher percentage of lymphoma-caused deaths. The post-transformation prognostic analyses demonstrated that female gender and age ≥ 65 years independently affected patients' mortalities. These findings, based on the largest cohort to date, contribute to a better understanding of transformed MZL, and provide valuable reference points for guidelines and patient counseling.
Keywords: Marginal zone lymphoma; Population-based study; Survival outcome; Transformation Risk.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Cerhan JR, Habermann TM (2021) Epidemiology of Marginal Zone Lymphoma. Ann Lymphoma ; 5. e-pub ahead of print 2021/04/09; https://doi.org/10.21037/aol-20-28
-
- Sriskandarajah P, Dearden CE (2017) Epidemiology and environmental aspects of marginal zone lymphomas. Best Pract Res Clin Haematol ; 30(1–2): 84–91. e-pub ahead of print 2017/03/16; https://doi.org/10.1016/j.beha.2016.07.002
-
- Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, of the World Health Organization Classification of Haematolymphoid Tumours (2022) The 5th edition: Lymphoid Neoplasms. Leukemia ; 36(7): 1720–1748. e-pub ahead of print 2022/06/23; https://doi.org/10.1038/s41375-022-01620-2
-
- Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The International Consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood 140(11):1229–1253 e-pub ahead of print 2022/06/03. https://doi.org/10.1182/blood.2022015851 - DOI - PubMed - PMC
-
- Cheah CY, Seymour JF (2023) Marginal zone lymphoma: 2023 update on diagnosis and management. Am J Hematol 98(10):1645–1657 e-pub ahead of print 2023/08/22. https://doi.org/10.1002/ajh.27058 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
